RU95106823A - Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида - Google Patents
Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спидаInfo
- Publication number
- RU95106823A RU95106823A RU95106823/04A RU95106823A RU95106823A RU 95106823 A RU95106823 A RU 95106823A RU 95106823/04 A RU95106823/04 A RU 95106823/04A RU 95106823 A RU95106823 A RU 95106823A RU 95106823 A RU95106823 A RU 95106823A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- retroviral
- succinoylaminohydroxyethylaminosulfonamides
- inhibition
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Abstract
Сукциноиламиногидроксиэтила миносульфонамидные соединения являются эффективными ингибиторами ретровирусных протеаз, а в частности, ингибиторами ВИЧ-протеазы.
Claims (1)
- Сукциноиламиногидроксиэтила миносульфонамидные соединения являются эффективными ингибиторами ретровирусных протеаз, а в частности, ингибиторами ВИЧ-протеазы.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93549092A | 1992-08-25 | 1992-08-25 | |
US07/935.490 | 1992-08-25 | ||
US07/935490 | 1992-08-25 | ||
PCT/US1993/007815 WO1994004491A1 (en) | 1992-08-25 | 1993-08-24 | N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95106823A true RU95106823A (ru) | 1996-11-20 |
RU2130016C1 RU2130016C1 (ru) | 1999-05-10 |
Family
ID=25467232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95106823A RU2130016C1 (ru) | 1992-08-25 | 1993-08-25 | Производные сукциноиламиногидроксиэтиламиносульфонамида, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции, способ лечения вич-инфекции |
Country Status (15)
Country | Link |
---|---|
US (2) | US5463104A (ru) |
EP (1) | EP0656886B1 (ru) |
JP (1) | JP4091653B2 (ru) |
KR (1) | KR100296461B1 (ru) |
AT (1) | ATE154800T1 (ru) |
AU (1) | AU674702B2 (ru) |
CA (1) | CA2142998C (ru) |
DE (1) | DE69311810T2 (ru) |
DK (1) | DK0656886T3 (ru) |
ES (1) | ES2103488T3 (ru) |
FI (1) | FI120342B (ru) |
GR (1) | GR3024181T3 (ru) |
NO (1) | NO302883B1 (ru) |
RU (1) | RU2130016C1 (ru) |
WO (1) | WO1994004491A1 (ru) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878728B1 (en) | 1999-06-11 | 2005-04-12 | Vertex Pharmaceutical Incorporated | Inhibitors of aspartyl protease |
US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
DK0656887T3 (da) | 1992-08-25 | 1999-07-05 | Searle & Co | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser |
US6022994A (en) * | 1992-08-25 | 2000-02-08 | G. D. Searle &. Co. | Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
US7141609B2 (en) | 1992-08-25 | 2006-11-28 | G.D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
US5783701A (en) * | 1992-09-08 | 1998-07-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
MX9603909A (es) * | 1994-03-07 | 1997-03-29 | Vertex Pharma | Derivados de sulfonamida como inhibidores de proteasa aspartilo. |
US5527829A (en) * | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
EP0804428B1 (en) | 1995-01-20 | 2007-12-26 | G.D. Searle LLC. | Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
US5691372A (en) * | 1995-04-19 | 1997-11-25 | Vertex Pharmaceuticals Incorporated | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
US6004957A (en) * | 1995-06-07 | 1999-12-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
DK0861233T3 (da) * | 1995-11-16 | 2000-08-07 | Searle & Co | N-Beskyttede/N-substituerede beta-aminohydroxysulfonater |
US5705647A (en) * | 1996-09-05 | 1998-01-06 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
US5962725A (en) * | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
US5925759A (en) | 1996-09-05 | 1999-07-20 | Agouron Pharmaceuticals, Inc. | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
DE19703713A1 (de) * | 1997-01-23 | 1998-07-30 | Hans Prof Dr Schick | Verfahren für die Herstellung von Oxetan-2-onen und Zwischenprodukte |
US6001851A (en) * | 1997-03-13 | 1999-12-14 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US6479669B2 (en) | 1997-05-09 | 2002-11-12 | Pharm-Eco Laboratories, Inc. | Amino acid derivatives and methods of making the same |
US6590106B2 (en) | 1997-05-09 | 2003-07-08 | Pharm-Eco Laboratories, Inc. | Amino acid derivatives and methods of making the same |
US6084107A (en) * | 1997-09-05 | 2000-07-04 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
EP1086076B1 (en) | 1998-06-19 | 2004-12-22 | Vertex Pharmaceuticals Incorporated | Sulfonamide inhibitors of aspartyl protease |
WO2000002862A1 (en) | 1998-07-08 | 2000-01-20 | G.D. Searle & Co. | Retroviral protease inhibitors |
US6506786B2 (en) | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
CN100549007C (zh) * | 2001-05-11 | 2009-10-14 | 泰博特克药品有限公司 | 广谱2-氨基-苯并唑磺酰胺hiv蛋白酶抑制剂 |
PT1471054E (pt) | 2002-01-11 | 2009-09-23 | Daiichi Sankyo Co Ltd | Derivado de aminoálcool ou derivado de ácido fosfónico e composição medicinal que os contém |
US7910617B2 (en) | 2004-02-24 | 2011-03-22 | Sankyo Company, Limited | Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound |
US7388008B2 (en) * | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
JP2008533017A (ja) * | 2005-03-11 | 2008-08-21 | スミスクライン ビーチャム コーポレーション | Hivプロテアーゼ阻害薬 |
EP1877091B1 (en) * | 2005-04-27 | 2015-03-25 | TaiMed Biologics, Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
JP2009517412A (ja) * | 2005-11-30 | 2009-04-30 | アンブリリア バイオファーマ インコーポレイテッド | アスパルチルプロテアーゼ阻害物質のリジンベースのプロドラッグ及びその調製方法 |
CA2664118A1 (en) | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Protease inhibitors |
DE102015001289A1 (de) | 2015-01-29 | 2016-08-04 | Wolfgang Winkelmann | Pharmazeutische Zusammensetzungen und Pflanzenschutzmittel enthaltend mit Sauerstoff angereicherte Pflanzenöle oder Fettsäuren |
CN107995910A (zh) * | 2015-04-23 | 2018-05-04 | Viiv保健英国第五有限公司 | 人免疫缺陷病毒复制的抑制剂 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
DE3377497D1 (en) * | 1982-09-15 | 1988-09-01 | Haessle Ab | Enzyme inhibitors |
US4668770A (en) * | 1982-12-27 | 1987-05-26 | Merck & Co., Inc. | Renin inhibitory tripeptides |
EP0114993B1 (en) * | 1982-12-27 | 1990-05-16 | Merck & Co. Inc. | Renin inhibitory tripeptides |
EP0118223A1 (en) * | 1983-02-07 | 1984-09-12 | Aktiebolaget Hässle | Enzyme inhibitors |
JPS59227851A (ja) * | 1983-06-09 | 1984-12-21 | Sankyo Co Ltd | レニン阻害作用を有するペプチド類 |
US4514391A (en) * | 1983-07-21 | 1985-04-30 | E. R. Squibb & Sons, Inc. | Hydroxy substituted peptide compounds |
US4477441A (en) * | 1983-09-14 | 1984-10-16 | Merck & Co., Inc. | Renin inhibitors containing a C-terminal disulfide cycle |
US4645759A (en) * | 1984-06-22 | 1987-02-24 | Abbott Laboratories | Renin inhibiting compounds |
US4616088A (en) * | 1984-10-29 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitor |
US4629724A (en) * | 1984-12-03 | 1986-12-16 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitors |
US4668769A (en) * | 1985-08-02 | 1987-05-26 | Hoover Dennis J | Oxa- and azahomocyclostatine polypeptides |
US4599198A (en) * | 1985-08-02 | 1986-07-08 | Pfizer Inc. | Intermediates in polypeptide synthesis |
CA1282549C (en) * | 1985-11-12 | 1991-04-02 | Eric M. Gordon | Aminocarbonyl renin inhibitors |
DE3542256A1 (de) * | 1985-11-29 | 1987-06-04 | Hoechst Ag | Vorrichtung zum kontinuierlichen schweissen bzw. siegeln von naehten von kunststoff-folien |
US4757050A (en) * | 1985-12-23 | 1988-07-12 | E. R. Squibb Sons, Inc. | Ureido renin inhibitors |
CA1297631C (en) * | 1985-12-23 | 1992-03-17 | Sesha I. Natarajan | Ureido renin inhibitors |
US4880938A (en) * | 1986-06-16 | 1989-11-14 | Merck & Co., Inc. | Amino acid analogs |
DE3635907A1 (de) * | 1986-10-22 | 1988-04-28 | Merck Patent Gmbh | Hydroxy-aminosaeurederivate |
DE3800591A1 (de) * | 1987-01-21 | 1988-08-04 | Sandoz Ag | Neue peptidderivate, ihre herstellung und verwendung |
NL8800100A (nl) * | 1987-01-21 | 1988-08-16 | Sandoz Ag | Nieuwe peptidederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. |
USH725H (en) * | 1987-02-26 | 1990-01-02 | E. R. Squibb & Sons, Inc. | Ureido amino and imino acids, compositions and methods for use |
GB8707412D0 (en) * | 1987-03-27 | 1987-04-29 | Fujisawa Pharmaceutical Co | Peptide compounds |
DE3830825A1 (de) * | 1987-09-15 | 1989-03-23 | Sandoz Ag | Hydrophile reninhemmer, ihre herstellung und verwendung |
IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
US4977277A (en) * | 1988-05-09 | 1990-12-11 | Abbott Laboratories | Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof |
IL90218A0 (en) * | 1988-05-13 | 1989-12-15 | Abbott Lab | Retroviral protease inhibitors |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
IL91307A0 (en) * | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
CA2012306A1 (en) * | 1989-03-28 | 1990-09-28 | Werner Neidhart | Amino acid derivatives |
JP2701932B2 (ja) * | 1989-04-10 | 1998-01-21 | サントリー株式会社 | タンパク質分解酵素阻害剤 |
DE3912829A1 (de) * | 1989-04-19 | 1990-10-25 | Bayer Ag | Verwendung von renininhibitorischen peptiden als mittel gegen retroviren |
TW225540B (ru) * | 1990-06-28 | 1994-06-21 | Shionogi & Co | |
DE69118907T2 (de) * | 1990-11-19 | 1996-11-14 | Monsanto Co | Retrovirale proteaseinhibitoren |
US5264457A (en) * | 1992-02-14 | 1993-11-23 | G. D. Searle & Co. | Phenyl amidines sulfonamides useful as platelet aggregation inhibitors |
DK0656887T3 (da) * | 1992-08-25 | 1999-07-05 | Searle & Co | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser |
-
1993
- 1993-08-24 JP JP50653194A patent/JP4091653B2/ja not_active Expired - Lifetime
- 1993-08-24 AT AT93920213T patent/ATE154800T1/de active
- 1993-08-24 ES ES93920213T patent/ES2103488T3/es not_active Expired - Lifetime
- 1993-08-24 EP EP93920213A patent/EP0656886B1/en not_active Expired - Lifetime
- 1993-08-24 DK DK93920213.1T patent/DK0656886T3/da active
- 1993-08-24 DE DE69311810T patent/DE69311810T2/de not_active Expired - Lifetime
- 1993-08-24 CA CA002142998A patent/CA2142998C/en not_active Expired - Lifetime
- 1993-08-24 US US08/110,912 patent/US5463104A/en not_active Expired - Lifetime
- 1993-08-24 WO PCT/US1993/007815 patent/WO1994004491A1/en active IP Right Grant
- 1993-08-24 KR KR1019950700730A patent/KR100296461B1/ko not_active IP Right Cessation
- 1993-08-25 RU RU95106823A patent/RU2130016C1/ru active
- 1993-08-25 AU AU50819/93A patent/AU674702B2/en not_active Expired
-
1995
- 1995-02-22 NO NO950670A patent/NO302883B1/no not_active IP Right Cessation
- 1995-02-23 FI FI950841A patent/FI120342B/fi not_active IP Right Cessation
- 1995-10-10 US US08/541,350 patent/US5714605A/en not_active Expired - Lifetime
-
1997
- 1997-07-22 GR GR970401826T patent/GR3024181T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3024181T3 (en) | 1997-10-31 |
CA2142998A1 (en) | 1994-03-03 |
NO950670D0 (no) | 1995-02-22 |
US5463104A (en) | 1995-10-31 |
CA2142998C (en) | 2008-01-29 |
AU5081993A (en) | 1994-03-15 |
RU2130016C1 (ru) | 1999-05-10 |
AU674702B2 (en) | 1997-01-09 |
JPH08500824A (ja) | 1996-01-30 |
JP4091653B2 (ja) | 2008-05-28 |
NO302883B1 (no) | 1998-05-04 |
NO950670L (no) | 1995-02-22 |
ATE154800T1 (de) | 1997-07-15 |
ES2103488T3 (es) | 1997-09-16 |
FI950841A (fi) | 1995-02-23 |
FI120342B (fi) | 2009-09-30 |
DE69311810D1 (de) | 1997-07-31 |
KR100296461B1 (ko) | 2001-11-14 |
FI950841A0 (fi) | 1995-02-23 |
EP0656886B1 (en) | 1997-06-25 |
DK0656886T3 (da) | 1998-02-02 |
US5714605A (en) | 1998-02-03 |
KR950702959A (ko) | 1995-08-23 |
WO1994004491A1 (en) | 1994-03-03 |
DE69311810T2 (de) | 1997-11-27 |
EP0656886A1 (en) | 1995-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95106823A (ru) | Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида | |
RU95106996A (ru) | Сульфонилалканоиламино-гидроксиэтиламино-сульфонамидные соединения, фармацевтические композиции и способы лечения и ингибирования ретровирусных протеаз | |
RU94028653A (ru) | Фармацевтический препарат | |
RU94046294A (ru) | Стероидные гликозиды для лечения гиперхолестеринэмии | |
MY131388A (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
MY138860A (en) | Hiv protease inhibitors. | |
NZ285846A (en) | Arylsulphonamido-substituted hydroxamic acids and preparation and medicaments useful for inhibiting metalloproteinases | |
NO893400L (no) | Hiv protease inhibitorer egnet for behandling av aids. | |
ES2145913T3 (es) | Inhibidores de metaloproteasas. | |
RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
ATE149488T1 (de) | Hiv-protease inhibitoren, verwendbar für die behandlung von aids | |
DE69019533D1 (de) | Behandlung von hiv-infizierungen und nützliche verbindungen dafür. | |
DE69518840D1 (en) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
DE69418035T2 (de) | Hiv-proteaseinhibitoren | |
ATE245444T1 (de) | Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen | |
DE69307674D1 (de) | HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS | |
ATE238062T1 (de) | Hemmung von hiv-infektion | |
RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
RU95106624A (ru) | Гидроксиэтиламиносульфонамиды, промежуточные соединения, фармацевтическая композиция, способ ингибирования ретровирусных протеаз, способ лечения ретровирусных инфекций, способ лечения спида | |
RU93055681A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях | |
RU93055683A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование, композиция | |
RU93055680A (ru) | Ингибиторы вич-протеазы, способ получения, их использование, композиция | |
RU93055684A (ru) | Соединения, ингибирующие вич-протеазу, способ их получения, фармацевтическая композиция, промежуточный продукт | |
DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen |